HughesGR. Thrombosis, abortion, cerebral disease and the lupus anticoagulant. BMJ1983; 287: 1088–1089.
2.
AvcinTCimazRSilvermanED. Pediatric antiphospholipid syndrome: Clinical and immunologic features of 121 patients in an international registry. Pediatrics2008; 122: 1100–1107.
3.
DaleRCYinKDingA. Antibody binding to neuronal surface in movement disorders associated with lupus and antiphospholipid antibodies. Dev Med Child Neurol2011; 53: 522–528.
4.
WeinerSGNormandinPA. Sydenham chorea: A case report and review of literature. Pediatric Emerg Care2007; 23: 20–24.
5.
TorreggianiSTorcolettiMCuocoFDi LandroGPetacciaACoronaF. Chorea, a little-known manifestation in systemic lupus erythematosus: Short literature review and four case reports. Pediatric Rheumatology Online J2013; 11: 36–36.
AvcinTSilvermanED. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome. Lupus2007; 16: 627–633.
8.
AvcinT. Antiphospholipid syndrome in children. Curr Opin Rheumatol2008; 20: 595–600.
9.
CerveraRAshersonRAFontJ. Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature. Medicine (Baltimore)1997; 76: 203–122.
10.
SolteszPDerHVeresK. Immunological features of primary anti-phospholipid syndrome in connection with endothelial dysfunction. Rheumatology (Oxford)2008; 47: 1628–1634.
11.
KatzavAChapmanJShoenfeldY. CNS dysfunction in the antiphospholipid syndrome. Lupus2003; 12: 903–907.
12.
WallkerKGWilmshurstJM. An update on the treatment of Sydenham’s chorea: The evidence for established and evolving interventions. Ther Adv Neurol Disord2010; 3: 301–309.
13.
CardosoF. Sydenham’s chorea. Current Treat Options Neurol2008; 10: 230–235.
14.
PelusoSAntenoraADe Rosa. Antiphospholipid-related chorea. Front Neurol2012; 3: 150–150.
15.
GenelFArslanogluSUranNSaylanB. Sydenham’s chorea: Clinical findings and comparison of the efficacies of sodium valproate and carbamazepine regimens. Brain Dev2002; 24: 73–76.
16.
CardosoFMaiaDCunninghamMCValençaC. Treatment of Sydenham chorea with corticosteroids. Mov Disord2003; 18: 1374–1377.
17.
PazJASilvaCAMarques-DiasMJ. Randomized double-blind study with prednisolone in Sydenham’s chorea. Pediatr Neurol2006; 4: 264–269.
18.
TeixeraALJrMaiaDPCardosoF. Treatment of acute Sydenham’s chorea with methylprednisolone pulse-therapy. Parkinsonism Relat Disord2005; 11: 327–330.
19.
FuscoCUcchinoVFrattiniDPisaniFDella GiustinaE. Acute and chronic corticosteroid treatment of ten patients with paralytic form of Sydenham’s chorea. Eur J Paediatr Neurol2012; 16: 373–378.
20.
van ImmerzeelTDvan GilstRMHartwigNG. Beneficial use of immunoglobulins in the treatment of Sydenham chorea. Eur J Pediatr2010; 169: 1151–1154.
21.
LazurovaIMacejovaZBenhatchiK. Efficacy of intravenous immunoglobulin treatment in lupus erythematosus chorea. Clin Rheumatol2007; 26: 2145–2147.
TsagalisGPsimenouENakopoulouLLaggouranisA. Effective treatment of antiphospholipid syndrome with plasmapheresis and rituximab. Hippokratia2010; 14: 215–216.
24.
GarveyMASniderLALeitmanSFWerdenRSwedoSE. Treatment of Sydenham’s chorea with intravenous immunoglobulin, plasma exchange, or prednisone. J Child Neurol2005; 20: 424–429.
25.
WalkerKBrinkALawewnsonJMathiassenWWilmshurstJM. Treatment of Sydenham chorea with intravenous immunoglobulin. J Child Neurol2012; 27: 147–155.
26.
AppenzellerSYehSMarujamaMBarrosSMde CarvalhoJF. Chorea in primary antiphospholipid syndrome is associated with rheumatic fever. Rheumatol Int2012; 32: 2857–2861.
27.
BlankMKrauseIMagriniL. Overlapping humoral and autoimmunity links rheumatic fever and the antiphospholipid syndrome. Rheumatology (Oxford)2006; 45: 833–841.
28.
Brogna C, Manna R, Olivieri, et al. Intravenous immunoglobulin therapy in pediatric antiphospholipid-related chorea. The Ninth International Congress on Autoimmunity, Session: PS18 – IVIG and Autoimmunity, Nice, France, 26–30 March 2014.
29.
RoutsiasJGKyriakidisNCFriedmanDM. Association of the idiotype: Antiidiotype antibody ratio with the efficacy of intravenous immunoglobulin treatment for the prevention of recurrent autoimmune-associated congenital heart block. Arthritis Rheum2011; 63: 2783–2789.